CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-08 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award | +13,750 | 204,139 | ||
| 2021-12-08 | Johnston Lloyd P. Chief Operations Officer | Grant or award | +13,750 | 111,085 | ||
| 2021-12-08 | Brunn Carsten President and CEO | Grant or award | +37,500 | 322,451 | ||
| 2021-12-03 | COX CARRIE SMITH Director | Purchase | +17,200 | $2.95 | $51K | 82,881 |
| 2021-12-02 | Tan Kevin Chief Financial Officer | Purchase | +5,000 | $3.03 | $15K | 5,000 |
| 2021-12-02 | DeSilva Nishan M Director | Purchase | +7,000 | $2.96 | $21K | 7,000 |
| 2021-12-02 | Brunn Carsten President and CEO | Sale | −4,746 | $2.96 | $14K | 284,951 |
| 2021-12-01 | Brunn Carsten President and CEO | Option exercise | +10,938 | 289,697 | ||
| 2021-12-01 | Brunn Carsten President and CEO | Option exercise · Restricted Stock Units | −10,938 | 43,750 | ||
| 2021-10-13 | TRABER PETER G Chief Medical Officer | Sale | −3,636 | $4.39 | $16K | 154,714 |
| 2021-10-13 | Kishimoto Takashi Kei Chief Scientific Officer | Sale | −3,892 | $4.39 | $17K | 190,389 |
| 2021-10-13 | Johnston Lloyd P. Chief Operations Officer | Sale | −3,892 | $4.39 | $17K | 97,335 |
| 2021-10-13 | Brunn Carsten President and CEO | Sale | −15,313 | $4.39 | $67K | 278,759 |
| 2021-10-01 | TRABER PETER G Chief Medical Officer | Grant or award | +13,750 | 158,350 | ||
| 2021-10-01 | Kishimoto Takashi Kei Chief Scientific Officer | Grant or award | +13,750 | 194,281 | ||
| 2021-10-01 | Johnston Lloyd P. Chief Operations Officer | Grant or award | +13,750 | 101,227 | ||
| 2021-10-01 | Brunn Carsten President and CEO | Grant or award | +37,500 | 294,072 | ||
| 2021-09-24 | TRABER PETER G Chief Medical Officer | Grant or award | +9,100 | 144,600 | ||
| 2021-09-24 | TRABER PETER G Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +54,400 | 54,400 | ||
| 2021-09-24 | Brunn Carsten President and CEO | Grant or award | +27,200 | 256,572 |
Page 23 of 25 · 495 trades